Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects
The purpose of this study is to determine how the human body processes and eliminates the drug (BMS-690514.
Cancer
DRUG: EVRI (BMS-690514)
Single dose pharmacokinetics of BMS-690514 and radioactivity in plasma and urine, measured for 10 days post-dose
Determination of biotransformation profiles and recorded adverse events, for 10 days post-dose
The purpose of this study is to determine how the human body processes and eliminates the drug (BMS-690514.